Search Results
Nov 04, 2025, 19:10 ET Ascletis Presents Full Analysis of Phase Ib Study of ASC30 Oral Tablet, Phase Ib Study of ASC30 Injection, and Preclinical Study of Combination of ASC31 and ASC47 at ObesityWeek® 2025
novel peptide agonist targeting both GLP-1R and GIPR, significantly outperformed both tirzepatide and ASC31 monotherapy in promoting weight loss, body fat loss, and muscle preservation in diet-induced obesity (DIO) mouse studies. -Presentations
More news about: Ascletis Pharma Inc.
Nov 04, 2025, 16:19 ET In Honor of American Diabetes Month, Danone North America to Host Reddit 'Ask Me Anything' In an Effort to Help Consumers Take Control of Their Health
health goals, including Light + Fit Original, Light + Fit Greek, Oikos Triple Zero, Activia Zero 0g Added Sugar, Activia Proactive, and Dannon Plain Low-fat and Nonfat yogurt. When portioned according to the ADA's
More news about: Danone USA
Nov 04, 2025, 16:05 ET Viking Therapeutics to Participate at Upcoming Investor Conferences
non-alcoholic fatty liver disease (NAFLD) and elevated LDL-C, patients who received VK2809 demonstrated statistically significant reductions in LDL-C and liver fat content compared with patients who received placebo. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin
More news about: Viking Therapeutics, Inc.
Nov 04, 2025, 16:01 ET MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek® 2025
When compared with pemvidutide, DA-1726 achieved similar body-weight reductions and improvements in body composition, including decreased fat mass and relatively preserved lean mass. Notably, DA-1726 delivered superior lipid-lowering benefits, showing greater reductions in total cholesterol,
More news about: MetaVia Inc.
Nov 04, 2025, 14:00 ET CIR-0602K Demonstrates Synergistic Metabolic Benefit with Tirzepatide: New Data Presented at ObesityWeek 2025
increased lean muscle mass, strength and metabolic function, together with metabolically beneficial shifts in adipose tissue phenotype ("bad fat" to "good fat"), both alone and on top of GLP-1 and GLP-1/GIP agonists. In combination with
More news about: Cirius Therapeutics
Nov 04, 2025, 09:03 ET FRIGO® CHEESE HEADS® SPOTLIGHTS CHEESE AS THE ULTIMATE SNACK IN THE ERA OF DAIRY
that cheese consumption is not associated with increased heart disease risk and that dairy foods at a range of fat levels can be part of a healthy diet. [Source: IDFA Messaging Guide: Full-Fat Dairy Is Back, October 2025] The Anticipation: As consumers and industry experts await
More news about: Saputo USA
Nov 04, 2025, 08:00 ET Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek®
reducing fat mass (preferentially VAT and android fat) and beneficial liver and bone health effects. As adjunct therapy to incretin mimetics, LPCN 2401 has potential to amplify GLP-1 action, ameliorate loss of muscle mass, improve muscle quality and functionality, and amplify fat mass loss
More news about: Lipocine Inc.
Nov 03, 2025, 19:03 ET HARLEY-DAVIDSON REVEALS SELECT NEW 2026 MOTORCYCLES SHIPPING SOON TO WORLDWIDE AUTHORIZED DEALERSHIPS
comfort. The Low Rider® S, Low Rider® ST, Heritage Classic, Breakout®, Fat Boy®, and Street Bob® Models: The diverse line of Harley-Davidson® Cruiser motorcycles includes six very
More news about: Harley-Davidson Motor Company
Nov 03, 2025, 08:17 ET Savor the Season at Red Robin with Holiday Celebration of Festive Flavor, Value and Gifting
Starting at just $16.99, guests can choose from fan-favorites like Cheesy Mozzarella Twists with marinara, Pretzel Bites with new Belgium Fat Tire® beer cheese, Boneless Chicken Bites tossed in a choice of dry rub or sauce, Crispy Fried Pickles with ranch, Zucchini
More news about: Red Robin Gourmet Burgers, Inc.
Nov 03, 2025, 08:00 ET Alcresta Therapeutics Announces FDA Clearance for Expanded Use of RELiZORB® (iMMOBILIZED LIPASE) Cartridge for Neonates and Infants
Alcresta Therapeutics. "Nutrition in this age group is critical to early development as systems in the body are maturing. Proper nutrition, including fat digestion and absorption, contributes to caloric requirements that support development of these systems throughout an infant's body. The real-world data
More news about: Alcresta Therapeutics, Inc.
Nov 03, 2025, 07:00 ET Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress
deaths worldwide.2 Both incidence and mortality have continued to rise.3,4 Key risk factors include obesity, type 2 diabetes, high-fat diets, tamoxifen or oral estrogen use, and delayed menopause.5 TP53 is a well-recognized prognostic marker for EC; >50% of advanced or
More news about: Karyopharm Therapeutics Inc.
Oct 31, 2025, 08:03 ET ComplexCon 2025 Draws Record-Breaking 70,000 Attendees in Las Vegas - The Largest in Event History
Sneaker of the Year panel, led by Joe La Puma, who was joined by Matthew Welty, Upscale Vandal, Brendan Dunne, Vashtie, and Fat Joe, crowned the Air Jordan 4 "Brick by Brick" designed by Nigel Sylvester as 2025's Sneaker of the Year. Following the panel, Sylvester pulled up
More news about: Complex
Oct 31, 2025, 08:00 ET Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock
biotechnology company whose novel engineered chemistry enables aqueous cytotoxic-containing drug formulations to mix and saturate a tumor's dense, high-fat, pressurized environment following direct intratumoral injection. As a result of the saturation, Intensity's clinical trials have demonstrated the
More news about: Intensity Therapeutics Inc.
Oct 30, 2025, 15:27 ET ATLANTIS PARADISE ISLAND ANNOUNCES 2026 NASSAU PARADISE ISLAND WINE & FOOD FESTIVAL
Carmine's remarkable 20-year journey at Atlantis. My Big Fat Mexican Italian Dinner with Aaron Sanchez & Antonia Lofaso – Vibrant Mexican flavors blend with Italian traditions at
More news about: Atlantis, Paradise Island
Oct 30, 2025, 07:30 ET Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal
biotechnology company whose novel engineered chemistry enables aqueous cytotoxic-containing drug formulations to mix and saturate a tumor's dense, high-fat, pressurized environment following direct intratumoral injection. As a result of the saturation, Intensity's clinical trials have demonstrated the
More news about: Intensity Therapeutics Inc.
Oct 29, 2025, 16:05 ET Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2025
non-alcoholic fatty liver disease (NAFLD) and elevated LDL-C, patients who received VK2809 demonstrated statistically significant reductions in LDL-C and liver fat content compared with patients who received placebo. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin
More news about: Viking Therapeutics, Inc.
Oct 29, 2025, 07:00 ET Withings' U-Scan Brings Urine Analysis into the Home
sufficiently meets metabolic and performance needs. Ketones: Ketone levels show when the body burns fat instead of sugar for energy (ketosis), helping assess fat metabolism, weight management, and adherence to low-carb diets. Vitamin C: As a water-soluble
More news about: Withings
Oct 29, 2025, 07:00 ET Gundry MD Announces the Launch of Longevitine Plus: A Revolutionary Longevity Support Formula
glutathione production for cellular defense and repair. Alitilix – A premium Italian artichoke extract that supports weight loss, fat metabolism, and digestive health. Shilajit – A powerful Himalayan antioxidant known to enhance mitochondrial function, boost
More news about: Gundry MD
Oct 28, 2025, 15:17 ET Food Can Coatings Market to Reach USD 5.68 Billion by 2032, Growing At An 2.8% CAGR - Credence Research
gained significant market share. The choice of coating is now a highly technical decision based on the specific type of food or beverage, its pH level, fat content, and the processing conditions it will undergo, such as sterilization or pasteurization. This complexity drives the need for close collaboration
More news about: Credence Research Inc.
Oct 28, 2025, 10:03 ET Utah State University Analysis Finds Diestel Regenerative Turkeys Deliver Superior Nutritional Benefits Compared to Conventional Birds, with Up to 79% More Omega-3s and 2-3x More Antioxidants
bird Healthier omega-6:3 ratios, being 1.5-2 times more favorable as commodity turkey Lower saturated fat levels in ground and whole regenerative turkey, contributing to a leaner overall lipid profile
More news about: Diestel Family Ranch
Oct 28, 2025, 10:00 ET TCI Biotech to Showcase Leadership as the "Liquid Expert" at SupplySide Global 2025, Featuring Clinically-Proven Innovations for Weight Management and Metabolic Health
Sugarlock™ (Peanut Skin Extract)A proprietary, allergen-free extract clinically shown to reduce fasting blood glucose by 7.4%, decrease body fat by 2%, and attenuate postprandial blood sugar spikes over a six-week intervention period.Outcomes were further validated through continuous
More news about: TCI; TCI Biotech
Oct 28, 2025, 08:35 ET Hanyang University Researchers Explore Role of Time-Restricted Eating in Controlling MASLD
strategy for MASLD management. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where excess fat builds up in the liver due to metabolic risk factors. The cornerstone for treating MASLD is managing the underlying metabolic risk factors through a
More news about: Hanyang University
Oct 27, 2025, 09:00 ET Queen Square Imaging Centre: New technique could improve outcomes for essential tremor patients
small and hard to visualise on standard MRI scans. FAT1 imaging overcomes this by giving surgeons a direct view of the individual patient's Vim, enabling treatment to be precise. "FAT1 imaging is a game-changer," said Mr Harith Akram, a consultant neurosurgeon
More news about: Queen Square Imaging Centre
Oct 27, 2025, 09:00 ET Queen Square Imaging Centre: New technique could improve outcomes for essential tremor patients
small and hard to visualise on standard MRI scans. FAT1 imaging overcomes this by giving surgeons a direct view of the individual patient's Vim, enabling treatment to be precise. "FAT1 imaging is a game-changer," said Mr Harith Akram, a consultant neurosurgeon
More news about: Queen Square Imaging Centre
Oct 27, 2025, 09:00 ET Queen Square Imaging Centre : une nouvelle technique pourrait améliorer les résultats pour les patients atteints de tremblement essentiel
les examens IRM standard. L'imagerie FAT1 permet de résoudre ce problème en donnant aux chirurgiens une vue directe du Vim de chaque patient, ce qui permet un traitement précis. « L'imagerie FAT1 change la donne », a déclaré M. Harith Akram, neurochirurgien
More news about: Queen Square Imaging Centre